Home / IVBXF : OTC

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does IVBXF make money? Does IVBXF have pricing power? What's the Earnings Whisper? Will IVBXF profit more as the business scales? What is IVBXF's management track record? Is IVBXF's current price justified?

Innovent Biologics, Inc.

$9.90 -$0.92 (-8.50%)

OTC · 30 Oct 2026 20:00 UTC

Previous Close

$11.30

Day Range

$9.90$11.10

Year Range

$9.10$15.01

Market Cap

17.26B

AVG Volume

2.17K

Trailing/Forward PE

95.4/4.56

PEG ratio

0.78

Dividend Yield

Next Earnings Date

2027-03-31

Primary Exchange

Other OTC

Revenue (CNY) · Q

IVBXF Revenue (CNY) by quarter
Period	Revenue (CNY)
26 Q2	8.5B
25 Q4	6.97B
25 Q2	5.95B
24 Q4	5.47B
24 Q2	3.95B
23 Q4	3.5B
23 Q2	2.7B
22 Q4	2.32B
22 Q2	2.24B
21 Q4	2.33B

Net Income (CNY) · Q

IVBXF Net Income (CNY) by quarter
Period	Net Income (CNY)
26 Q2	1.24B
25 Q4	-20.41M
25 Q2	834.32M
24 Q4	297.99M
24 Q2	-392.62M
23 Q4	-888.76M
23 Q2	-139.15M
22 Q4	-1.23B
22 Q2	-950.47M
21 Q4	-1.73B

Operating Income (CNY) · Q

IVBXF Operating Income (CNY) by quarter
Period	Operating Income (CNY)
26 Q2	1.88B
25 Q4	715.65M
25 Q2	773.55M
24 Q4	-15.19M
24 Q2	-740.69M
23 Q4	-960.46M
23 Q2	-718.85M
22 Q4	-1.67B
22 Q2	-1.45B
21 Q4	-1.72B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (CNY) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 31 Mar 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Innovent Biologics, Inc.

Earnings: IVBXF

Video analysis: IVBXF

News: IVBXF

Similar companies